EVAX

Evaxion A/S

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$2.77

Price (1 Year)

$6.21 $2.77

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %23.5 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %39.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia.

Website

Analysis (Turkish): EVAX Hissesi Caiz mi, Helal mi? Evaxion A/S Katılım Analizi